Pacific Biosciences (NQ: PACB )

2.311 +0.011 (+0.49%)

Streaming Delayed Price Updated: 10:31 AM EST, Nov 11, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Pacific Biosciences

PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm

August 02, 2024

From The Schall Law Firm

Via Business Wire

Strategic Buy Lights Up This Biotech Stock: Time to Invest?

July 16, 2024

Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.

Via MarketBeat

Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices

June 27, 2024

Via ACCESSWIRE

PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care

August 07, 2023

Study is first of its kind to compare diagnostic rates across short- and long-read sequencing platforms

From GeneDx Holdings Corp.; PacBio

Via GlobeNewswire

Pacific Biosciences (NASDAQ: PACB) Making Surprising Moves in Friday Session

March 31, 2023

Via Investor Brand Network

Earlier Screening and Aging Population Driving Surging Growth in Colorectal Diagnostics Demand

November 11, 2021

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force...

Via FinancialNewsMedia

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.